Mallinckrodt Public Limited Company (NYSE:MNK) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Mallinckrodt Public Limited Company (NYSE:MNK) gained 2.62 Percent and closed its previous trading session at $21.51. The stock traded with the average Volume of 3.32 Million at the end of last session.
Mallinckrodt Public Limited Company (NYSE:MNK) has the Market Capitalization of 1.85 Billion. The Stock has its 52-week High of $49.12 and 52-Week Low of $11.65 and it touched its 52-week high on 07/25/17 and 52-Week Low on 05/04/18
The company reported its last earnings Actual EPS of $1.31/share. While, the analyst predicted that the company could provide an EPS of $1.08/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.23/share which shows an Earnings Surprise of 21.3 Percent.
Sell side analysts plays vital role in buying and selling a stock where 1 analysts rated Mallinckrodt Public Limited Company (NYSE:MNK) as Buy, 0 analysts given Outperform signal, 3 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 10.24% where SMA50 and SMA200 are 24.38% and 4.23% respectively.
The company shows its Return on Assets (ROA) value of 11.4%. The Return on Equity (ROE) value stands at 29.6%. While it’s Return on Investment (ROI) value is 12.6%.
Mallinckrodt Public Limited Company (NYSE:MNK) currently has a Weekly Volatility of 4.58% percent while its Monthly Volatility is at 4.56% percent. While talking about Performance of the Stock, Mallinckrodt Public Limited Company currently has a Weekly performance of 11.62%, monthly performance percentage is 12.74 percent, Quarterly performance is 54.86 percent, 6 months performance shows a percent value of -3.93% and Yearly Performance is -51.22 percent.
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.